Genomics

Dataset Information

0

Androgen deprivation therapy promotes an inflammatory and obesity-like microenvironment in periprostatic fat


ABSTRACT: Prostate cancer is a leading cause of cancer-related death and morbidity worldwide. Androgen deprivation therapy (ADT) is the cornerstone of management for advanced disease. The use of androgen deprivation therapies is associated with multiple side effects, including metabolic syndrome and truncal obesity. At the same time, obesity has been associated with both prostate cancer development and disease progression, linked to its effects on chronic inflammation at a tissue level. The connection between androgen deprivation therapy, obesity, inflammation, and prostate cancer progression is well-established in clinical settings; however, an understanding of the changes in adipose tissue at the molecular level induced by castrating therapies is missing. Here we investigated the transcriptional changes in periprostatic fat tissue induced by profound androgen deprivation therapy in a group of patients with high-risk tumours compared to a matching untreated cohort. We find that androgen deprivation therapy is associated with a pro-inflammatory and obesity-like adipose tissue microenvironment. This study suggests that the beneficial effect of androgen deprivation therapy may be partially counteracted by metabolic and inflammatory side effects in the adipose tissue surrounding the prostate.

PROVIDER: EGAS00001003286 | EGA |

REPOSITORIES: EGA

Similar Datasets

2012-12-01 | GSE28680 | GEO
2012-12-01 | E-GEOD-28680 | biostudies-arrayexpress
2008-04-07 | E-GEOD-8702 | biostudies-arrayexpress
2018-08-21 | PXD009868 | Pride
2011-12-06 | E-GEOD-33316 | biostudies-arrayexpress
2011-12-06 | GSE33316 | GEO
2021-07-23 | GSE180270 | GEO
2021-10-27 | GSE160684 | GEO
2007-10-25 | GSE8466 | GEO
2008-02-29 | GSE8702 | GEO